Evidence map›Paper›PMID 29941546›Full record

ArticleJournal of investigative medicine : the official publication of the American Federation for Clinical Research2018

Evaluation of liver test abnormalities in a patient-centered medical home: do liver test patterns matter?

Andrew D Schreiner, William P Moran, Jingwen Zhang, Elizabeth B Kirkland, Marc E Heincelman, Samuel O Schumann Iii, Patrick D Mauldin, Don C Rockey

Abstract readEvaluation Study
In one paragraph

Article in Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. The utility of liver biopsy in 2020.Current opinion in gastroenterology · 2020
    Review
  3. Abnormal Liver Enzymes.Journal of general internal medicine · 2019
    Article
  4. When Do Clinicians Follow-up Abnormal Liver Tests in Primary Care?The American journal of the medical sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrew D SchreinerDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
William P MoranDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Jingwen ZhangDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Elizabeth B KirklandDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Marc E HeincelmanDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Samuel O Schumann IiiDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Patrick D MauldinDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Don C RockeyDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.

Funding

Improving the Diagnosis of Liver Disease in Primary Care Patients with Abnormal Liver FunctionK23DK118200 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SCHREINER, ANDREW DAVID · 2018 to 2022
$866k
NIDDK NIH HHS K23 DK118200
6 · The paper itself

Abstract

Abnormal liver tests are extremely common in clinical practice, present with varying patterns and degrees of elevation, and can signal liver injury from a variety of causes. Responding to these abnormalities requires complex medical decision-making and merits investigation in primary care. This retrospective study investigates the association of patterns of liver test abnormality with follow-up in primary care. Using administrative data, this study includes patients with abnormal liver tests seen between 2007 and 2016 in a patient-centered medical home. Liver tests examined include serum bilirubin, aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase. Patients entered the cohort on the first liver test elevation. The outcome examined was completion of repeat testing, and the proportions of patients without follow-up were compared by patterns of index abnormality. 9545 patients met the inclusion criteria. Of these, 6155 (64.5%) possessed one liver test abnormality and 3390 (35.5%) possessed multiple abnormalities on index testing. Overall 1119 (11.7%) patients did not have repeat testing performed during the study period. A greater proportion of patients with lone abnormalities lacked repeat testing compared with those patients with multiple abnormalities. Differences in repeat testing appeared when comparing clinical patterns of abnormality, with higher proportions of follow-up in patients with testing suggestive of cholestasis. Over 11% of patients with abnormal liver tests did not undergo repeat testing during the study period. Repeat testing occurred more often in patients with multiple abnormalities and in clinical patterns suggestive of cholestasis. This study highlights a potential opportunity to improve quality of care.

Indexed as

Patient-Centered CareAlanine TransaminaseAlkaline PhosphataseAspartate AminotransferasesCohort StudiesFemaleFollow-Up StudiesHumansLiver Function TestsMaleMiddle AgedAlanine TransaminaseAlkaline PhosphataseAspartate Aminotransferasesdiagnostic tests, routineliver diseasesmedical researchprimary health care

Identifiers

PMID29941546
PMCPMC6482948

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.